Gastric adenocarcinoma diagnosed alongside a separate retroperitoneal liposarcoma
This gastric cancer diagnosis at a glance
- Subtype
- Adenocarcinoma
- Sex
- male
- Treatment
- chemotherapy
- Outcome
- In Memory
Treatment course, step by step
- He received 2 courses of cisplatin plus S-1 chemotherapy.
- The gastric tumor remained stable or became slightly smaller during treatment.
What happened, in summary
A man in his 70s sought care for poor appetite and a 4-kg weight loss over 2 months. Endoscopy showed a large gastric tumor extending from the antrum into the duodenal bulb, and biopsy found moderately to poorly differentiated adenocarcinoma. CT also showed enlarged regional lymph nodes and a large retroperitoneal mass. The retroperitoneal lesion was initially thought to be metastatic gastric cancer, so the gastric cancer was clinically treated as advanced disease.
He received 2 courses of cisplatin plus S-1 chemotherapy. The stomach cancer remained stable or slightly smaller, but the retroperitoneal mass grew rapidly and developed central necrosis. Biopsy of that mass showed a high-grade spindle-cell tumor rather than adenocarcinoma. Over the following weeks it enlarged further, causing pain, ascites and compression of major abdominal vessels.
He died 3.5 months after admission from hepatorenal failure associated with severe jaundice. Autopsy clarified that the retroperitoneal tumor was a separate dedifferentiated liposarcoma. The gastric tumor remained an adenocarcinoma with regional lymph-node involvement and treatment effect, but there was no distant organ metastasis from the gastric cancer. The rapidly progressive liposarcoma caused the major abdominal complications in his final months.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Chemotherapy for Gastric Cancer 98 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer